Clinical Trials Logo

Myopia, Degenerative clinical trials

View clinical trials related to Myopia, Degenerative.

Filter by:

NCT ID: NCT06405711 Not yet recruiting - Myopia, Progressive Clinical Trials

To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia

Start date: May 2024
Phase: N/A
Study type: Interventional

To confirm the efficacy of DIMS lenses in controlling myopia progression, we planned a prospective, single-centre, randomised, double-blind, controlled, non-inferiority clinical study.

NCT ID: NCT06389110 Not yet recruiting - Myopia Clinical Trials

Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.

Start date: December 30, 2024
Phase: Phase 3
Study type: Interventional

Phase III clinical study to evaluate the efficacy of Alleance® (atropine sulfate 0.01%) ophthalmic solution through the incidence of unexpected adverse events, changes in Best Corrected Visual Acuity (BCVA), changes in intraocular pressure, changes in the amplitude of accommodation, compared to placebo, as a treatment to delay the progression of myopia and axial ocular elongation in children.

NCT ID: NCT06250920 Completed - Myopia Clinical Trials

Effect of Virtual Reality-Based Visual Training for Myopia Control in Children

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

To assess the efficacy and safety of virtual reality-based visual training (VRVT) in myopia control among children.

NCT ID: NCT06221592 Not yet recruiting - Myopia, Progressive Clinical Trials

Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

To evaluate the differences in controlling the progression of myopia in adolescents and the safety and comfort of wearing different types of defocus incorporated multiple segments spectacle lenses, to explore the feasibility of effective defocus micro lens design, and apply personalized defocus frame lenses for myopia prevention and control.

NCT ID: NCT06088225 Recruiting - Myopia, Progressive Clinical Trials

Myopia Preventing With Distance-image Screen

DIS
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

This study is for testing the efficacy and safety of distance-image screens for preventing myopia in children for 12 month. Each subjects would be asked to paired test the ocular parameters between before and after 12-month distance-image screens.

NCT ID: NCT06085430 Not yet recruiting - Myopia Clinical Trials

Kubota Glass Parameter Refinement Study

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Length of the eye will be measured in subjects exposed to various stimulus characteristics using an electronic spectacle which presents illuminated targets to the eye. The results will be analyzed to determine which stimulus characteristics may be most beneficial for use in the device.

NCT ID: NCT06071260 Not yet recruiting - Myopia, Progressive Clinical Trials

Effect of Atropine on Pupil Size and Quality of Vision

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This aims to investigated the short-term (12, 16, and 20 h) effects of 0.01% atropine (0.1 mg/ml) on pupil size and subjective quality of vision in participants with myopia. Particpants will receive 0.01% atropine one drop to both eyes before bedtime. Baseline parameters were measured before atropine application. Changes in pupil sizes, under photopic and mesopic conditions, high-order aberration, and tear meniscus height were observed over the next day (12, 16, and 20 h).

NCT ID: NCT05955638 Not yet recruiting - Myopia, Progressive Clinical Trials

Management of Myopia in University Students Using Dual Focus Soft Contact Lenses

MoMUS
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to quantify the effectiveness of Coopervision MiSight contact lenses in slowing the rate of myopia progression in university students.

NCT ID: NCT05939882 Recruiting - Myopia, Progressive Clinical Trials

Low Concentration Atropine in the Prevention of Myopia in Children.

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This double-blind, randomized controlled clinical study is to evaluate the effectiveness and safety of low concentration atropine in preventing myopia in pre-myopia children, and to explore whether there is a dose effect relationship between different concentrations of atropine in preventing myopia.

NCT ID: NCT05919654 Active, not recruiting - Myopia, Progressive Clinical Trials

Clinical Evaluation of MyoCare in Europe (CEME)

CEME
Start date: September 15, 2022
Phase: N/A
Study type: Interventional

A 2-year prospective, multicenter, randomized controlled, and double-blind clinical trial is used to investigate the efficacy of a new design of ophthalmic lenses to slow the progression of myopia. 300 children aged from 6 to 13 years old will be recruited and randomly assigned to a study or control group. The study group will be composed of 150 children wearing MyoCare while the control group will be composed of 150 children wearing Clearview. The inclusion criteria will be myopia with a spherical equivalent between -0.75D and -5.00D, astigmatism < 1.50D, and anisometropia < 1.00D, as well as having a historical evolution of at least -0.50 The primary outcome is to compare the mean annual progression of the spherical equivalent between both groups. The secondary outcomes are axial length, choroidal thickness, phorias, and accommodative status of both groups.